Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FMXFP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,816
Award facts
- Contract value 100% obligated
- $52,816.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,816.26 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The SPE2DX IDC enables the contractor to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Dupixent, a biologic medication used primarily for asthma and atopic dermatitis treatment, exemplifies the contractor's role in providing specialized medications to support military and veteran healthcare needs through the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FMXFP?
SPE2DB25FMXFP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FMXFP worth?
The government has obligated $52,816 on SPE2DB25FMXFP.
Is contract SPE2DB25FMXFP an order under another contract?
Yes. SPE2DB25FMXFP is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMXFP competed?
The extent of competition for SPE2DB25FMXFP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award